Search

everythinglearnresearchcommunity

for

Search:↓

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Common gene patterns may cause skin autoimmune diseases.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Neuropeptides affect skin inflammation, repair, and hair growth, with potential for therapy.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

New psoriasis treatments are effective but come with side effects and risks.

The study found no link between vitamin D deficiency and psoriasis but suggests more research is needed.

A young child with alopecia areata and psoriasis improved with treatment, suggesting a link between the two conditions.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Alopecia areata does not affect areas with psoriasis plaques.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Secukinumab for psoriasis may cause hair loss.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Smart microneedles using advanced tech could improve psoriasis treatment.